A concise and high-yielding double aza-Michael reaction is presented as an atom-efficient method to access chiral 2-substituted 4-piperidone building blocks from divinyl ketones. The piperidones were further converted into analogues of donepezil, an acetylcholinesterase inhibiting drug used in the treatment of Alzheimer's disease. The donepezil analogues were obtained as inseparable diastereomeric mixtures with resolved stereochemistry in position 2 of the piperidine ring. Biological evaluation of the acetylcholinesterase inhibition by these analogues provides a new insight into structure-Activity relationship studies with regard to donepezil's piperidine moiety toward stereochemical enhancement.</p
The reactivity of 2-(2-mesyloxyethyl)azetidines, obtained through monochloroalane reduction and mesy...
A novel series of donepezil-tacrine hybrids designed to simultaneously interact with the active, per...
Donepezil is the most prescribed drug for mild to moderate Alzheimer's Disease. There is not any alt...
Das Medikament Donepezil, das in der Behandlung von Morbus Alzheimer verwendet wird, verhindert den ...
Alzheimer’s disease (AD) is a widespread multifactorial aging-related pathology, which includes chol...
Design, synthesis and evaluation of new acetylcholinesterase inhibitors by combining carbamoylpiperi...
International audienceNitrogen-encompassing bioactive molecules can be regarded as the most frequent...
New series of indole derivatives analogous to donepezil, a well known anti-Alzheimer and acetylcholi...
International audienceThis work aims at exploiting both the enantioselective Tsuji allylation of all...
The activity of pharmacologically active compounds can be increased by presenting a drug in a define...
A series of 22 donepezil analogues were synthesized through alkylation/benzylation and compared to d...
As part of an in-house project, the CSIR-housed BioFocus library composed of approximately 20’000 th...
Piperazines are widely used as central elements in the construction of bioactive molecules. Herein, ...
none10siAlzheimer disease (AD) is a complex disease related to multiple pathogenic mechanisms. A str...
Four series of novel heterodimers comprised of donepezil and huperzine A (HupA) fragments were desig...
The reactivity of 2-(2-mesyloxyethyl)azetidines, obtained through monochloroalane reduction and mesy...
A novel series of donepezil-tacrine hybrids designed to simultaneously interact with the active, per...
Donepezil is the most prescribed drug for mild to moderate Alzheimer's Disease. There is not any alt...
Das Medikament Donepezil, das in der Behandlung von Morbus Alzheimer verwendet wird, verhindert den ...
Alzheimer’s disease (AD) is a widespread multifactorial aging-related pathology, which includes chol...
Design, synthesis and evaluation of new acetylcholinesterase inhibitors by combining carbamoylpiperi...
International audienceNitrogen-encompassing bioactive molecules can be regarded as the most frequent...
New series of indole derivatives analogous to donepezil, a well known anti-Alzheimer and acetylcholi...
International audienceThis work aims at exploiting both the enantioselective Tsuji allylation of all...
The activity of pharmacologically active compounds can be increased by presenting a drug in a define...
A series of 22 donepezil analogues were synthesized through alkylation/benzylation and compared to d...
As part of an in-house project, the CSIR-housed BioFocus library composed of approximately 20’000 th...
Piperazines are widely used as central elements in the construction of bioactive molecules. Herein, ...
none10siAlzheimer disease (AD) is a complex disease related to multiple pathogenic mechanisms. A str...
Four series of novel heterodimers comprised of donepezil and huperzine A (HupA) fragments were desig...
The reactivity of 2-(2-mesyloxyethyl)azetidines, obtained through monochloroalane reduction and mesy...
A novel series of donepezil-tacrine hybrids designed to simultaneously interact with the active, per...
Donepezil is the most prescribed drug for mild to moderate Alzheimer's Disease. There is not any alt...